4DEG | pdb_00004deg

Crystal structure of c-Met in complex with triazolopyridazine inhibitor 2


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 
    0.254 (Depositor), 0.247 (DCC) 
  • R-Value Work: 
    0.206 (Depositor), 0.204 (DCC) 
  • R-Value Observed: 
    0.209 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 4DEG

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitors.

Bode, C.M.Boezio, A.A.Albrecht, B.K.Bellon, S.F.Berry, L.Broome, M.A.Choquette, D.Dussault, I.Lewis, R.T.Lin, M.H.Rex, K.Whittington, D.A.Yang, Y.Harmange, J.C.

(2012) Bioorg Med Chem Lett 22: 4089-4093

  • DOI: https://doi.org/10.1016/j.bmcl.2012.04.072
  • Primary Citation Related Structures: 
    4DEG, 4DEH, 4DEI

  • PubMed Abstract: 

    Deregulation of the receptor tyrosine kinase c-Met has been implicated in several human cancers and is an attractive target for small molecule drug discovery. Herein, we report the discovery of a structurally diverse series of carbon-linked quinoline triazolopyridinones, which demonstrates nanomolar inhibition of c-Met kinase activity. This novel series of inhibitors exhibits favorable pharmacokinetics as well as potent inhibition of HGF-mediated c-Met phosphorylation in a mouse liver pharmacodynamic model.


  • Organizational Affiliation
    • Amgen Inc., 360 Binney St., Cambridge, MA 02142, USA. aboezio@amgen.com

Macromolecule Content 

  • Total Structure Weight: 35.62 kDa 
  • Atom Count: 2,523 
  • Modeled Residue Count: 286 
  • Deposited Residue Count: 309 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Hepatocyte growth factor receptor309Homo sapiensMutation(s): 0 
Gene Names: MET
EC: 2.7.10.1
UniProt & NIH Common Fund Data Resources
Find proteins for P08581 (Homo sapiens)
Explore P08581 
Go to UniProtKB:  P08581
PHAROS:  P08581
GTEx:  ENSG00000105976 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP08581
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
0JJ

Query on 0JJ



Download:Ideal Coordinates CCD File
B [auth A]7-methoxy-N-{[6-(3-methyl-1,2-thiazol-5-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}-1,5-naphthyridin-4-amine
C19 H16 N8 O S
QMWKLCXWSJTEFT-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free:  0.254 (Depositor), 0.247 (DCC) 
  • R-Value Work:  0.206 (Depositor), 0.204 (DCC) 
  • R-Value Observed: 0.209 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 42.042α = 90
b = 43.012β = 90
c = 157.954γ = 90
Software Package:
Software NamePurpose
SCALEPACKdata scaling
REFMACrefinement
PDB_EXTRACTdata extraction
CrystalCleardata collection
DENZOdata reduction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2012-05-30
    Type: Initial release
  • Version 1.1: 2012-06-20
    Changes: Database references
  • Version 1.2: 2024-02-28
    Changes: Data collection, Database references, Derived calculations